Feuerstein GZ, Firestein R, Marcinkiewicz C (2025) Development an Innovative, Contrarian and Unprecedented Theragnostic Technology based on Submicron Fluorescent Diamond Particles, FDP-NV-750NM Coated with Doxorubicin and Duplex Sorafenib. PART II: - In Vivo Proof of Hypotheses and Technical Feasibility for Direct to Tumor Injection of FDP-NV-DOX~SOR to Xenograft Tumors in Immune Compromised BALB/C2 ‘NUDE’ Mice. Int J Nano Rech Vol: 8, Issu: 1 (01-19).